Morningstar Investor users sign in here.

Company Profile

  • Business description

    Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

  • Contact

    85 Wells Avenue
    2nd Floor
    Newton MA 02459
    USA

    T: +1 617 658-0600

    E: ikarp@karyopharm.com

    https://www.karyopharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    325

Stocks News & Analysis

stocks

How to assess a company’s debt load

BHP is used as an example to show how to assess the impact of too much debt on financial risk and flexibility.
stocks

Top ASX banking opportunities

Bank shares rally as bad debt concerns ease but look overvalued.
video

The impact on investors from Facebook's about face on news

Morningstar's Director of Equity Research Brian Han talks about why Facebook decided not to renew media deals and the impact for the companies and investors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,050.20 23.90 -0.30%
CAC 40 8,010.83 12.91 -0.16%
DAX 40 17,930.32 24.16 -0.13%
Dow JONES (US) 37,983.24 475.84 -1.24%
FTSE 100 7,995.58 71.78 0.91%
HKSE 16,721.69 373.34 -2.18%
NASDAQ 16,175.09 267.10 -1.62%
Nikkei 225 39,523.55 80.92 0.21%
NZX 50 Index 11,931.32 2.99 -0.03%
S&P 500 5,123.41 75.65 -1.46%
S&P/ASX 200 7,788.10 25.50 -0.33%
SSE Composite Index 3,019.47 14.77 -0.49%

Market Movers

Name
Last price
Change
% Change
The Star Entertainment Group Ltd SGR 0.51 0.04 -7.34%
Peninsula Energy Ltd PEN 0.11 0.01 -4.55%
Red 5 Ltd RED 0.43 0.03 6.17%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Judo Capital Holdings Ltd JDO 1.38 0.00 0.00%
Genex Power Ltd GNX 0.27 0.02 6.00%
Imugene Ltd IMU 0.09 0.00 -3.16%
Pantoro Ltd PNR 0.08 0.00 3.70%
Telstra Group Ltd TLS 3.76 0.04 -1.05%
Pilbara Minerals Ltd PLS 4.05 0.03 0.75%